Nucleosides

adenosine A3 receptor ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33472058 N6-methyladenosine (m6A) is an endogenous A3 adenosine receptor ligand. 2021 Feb 18 1
2 34435786 Subtle Chemical Changes Cross the Boundary between Agonist and Antagonist: New A3 Adenosine Receptor Homology Models and Structural Network Analysis Can Predict This Boundary. 2021 Sep 9 1
3 33062176 Direct Comparison of (N)-Methanocarba and Ribose-Containing 2-Arylalkynyladenosine Derivatives as A3 Receptor Agonists. 2020 Oct 8 1
4 26890707 Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3 Adenosine Receptor Agonists. 2016 Apr 14 1
5 25973142 John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors. 2015 1
6 26236460 Structure-Based Design, Synthesis by Click Chemistry and in Vivo Activity of Highly Selective A3 Adenosine Receptor Agonists. 2015 2
7 23789857 Rational design of sulfonated A3 adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain. 2013 Jul 25 1
8 21992803 Affinity prediction on A3 adenosine receptor antagonists: the chemometric approach. 2011 Nov 15 1
9 19375920 Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists. 2009 May 15 1
10 19077268 Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000. 2008 Dec 12 1
11 17542617 Probing the binding site of the A1 adenosine receptor reengineered for orthogonal recognition by tailored nucleosides. 2007 Jun 26 1
12 17149867 2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists. 2006 Dec 14 1
13 11708915 Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides. 2001 Nov 22 1